CRISPR Therapeutics AG - Common Shares (CRSP)

$45.33 0.82 (1.84%)

10:50 EST CRSP Stock Quote Delayed 30 Minutes

3 Biotech Blockbusters to Turn $5,000 Into $50,000

By Omor Ibne Ehsan Sep 12, 2023

These transformative early-stage biotech stocks can deliver triple-digit upside if their key milestones are achieved on time.

CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

Stocks to Watch This Week’s Top 7 Wall Street Upgrades

Volume:

Previous Close -

Market Cap 3.58B

PE Ratio -10.42

EPS -4.35

Volume (Avg. Vol.) 329,030

Day's Range $44.25 - $45.68

52-Week Range $36.52 - $90.62

Dividend & Yield N/A (N/A)

CRSP Stock Predictions, Articles, and CRISPR Therapeutics AG - Common Shares News

The 3 Most Undervalued Cathie Wood Stocks to Buy Now: August 2023

By Jeremy Flint, InvestorPlace Contributor Aug 16, 2023

Even if Cathie Wood stocks in ARK fell from grace, these three portfolio picks remain undervalued and ideal investments.

The 3 Best Biotech Stocks to Buy in August

By Jeremy Flint, InvestorPlace Contributor Aug 9, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

3 Biotech Stocks That Analysts Are Drooling Over

By Josh Enomoto, InvestorPlace Contributor Aug 7, 2023

With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time.

3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now

By Jeremy Flint, InvestorPlace Contributor Aug 2, 2023

Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.

3 Tech Stocks to Watch for Groundbreaking Innovations in 2030

By Chris Markoch, InvestorPlace Contributor Jul 19, 2023

If you’re a speculative investor here are three companies that are on the leading edge of what may be groundbreaking innovations by 2030.

3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025

By Chris Markoch, InvestorPlace Contributor Jul 5, 2023

In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025

3 Stocks That Every 20-Year-Old Should Buy Today

By Josh Enomoto, InvestorPlace Contributor Jul 2, 2023

When you’re just starting out in adult life, you have time on your side. Use it to your advantage with these stocks for young investors.

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023

By Ian Cooper, InvestorPlace Contributor Jun 29, 2023

If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023

By Omor Ibne Ehsan Jun 28, 2023

Bard AI has consistently outperformed its peers regarding stock picking, and it has identified seven growth stocks that it believes will deliver triple-digit returns this year.

3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever

By Chris Markoch, InvestorPlace Contributor Jun 20, 2023

Here are three long-term biotech stock investments that have the opportunity to turn risk -tolerant investors into millionaires.

5 Stocks to Buy With Explosive 500% Potential

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Jun 12, 2023

Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.

Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?

By William White, InvestorPlace Writer Jun 9, 2023

CRISPR Therapeutics (CRSP) stock is on the move Friday after the company revealed data from its CLIMB-111 and CLIMB-121 clinical trials.

Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today?

By Samuel O'Brient, InvestorPlace Reporter Jun 6, 2023

Gene editing stocks are up today on news that Editas Medicine will present clinical data on June 12. Here's what this means for the sector.

3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat

By Faizan Farooque, InvestorPlace Contributor Apr 25, 2023

Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.

The Top 3 Biotech Stocks to Watch in 2023

By Ian Cooper, InvestorPlace Contributor Apr 20, 2023

Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.

Cathie Wood Just Bought More CRISPR Therapeutics (CRSP) Stock

By Eddie Pan, InvestorPlace Financial News Writer Apr 13, 2023

Shares of CRSP stock are moving higher following an initiation of coverage by Cantor Fitzgerald and continued buys from Cathie Wood.

Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?

By Josh Enomoto, InvestorPlace Contributor Apr 13, 2023

While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks.

The 3 Best Growth Stocks to Buy in the Biotech Sector

By Ian Cooper, InvestorPlace Contributor Mar 29, 2023

These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.

7 Biotech Stocks to Buy for Breakthrough Treatments and Cures

By Josh Enomoto, InvestorPlace Contributor Mar 29, 2023

For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket

By Ian Cooper, InvestorPlace Contributor Mar 25, 2023

Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.

CRISPR Therapeutics AG - Common Shares (CRSP)

3 Biotech Blockbusters to Turn $5,000 Into $50,000

CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

Stocks to Watch This Week’s Top 7 Wall Street Upgrades

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CRISPR Therapeutics AG - Common Shares (CRSP)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CRSP Stock Predictions, Articles, and CRISPR Therapeutics AG - Common Shares News

Subscriber Sign in